Bacterial Resistance to Antibiotics: From Molecules to Man | Agenda Bookshop Skip to content
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Boyan B. Bonev
B01=Nicholas M. Brown
Category1=Non-Fiction
Category=PSAF
Category=PSGD
COP=United Kingdom
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€20 to €50
PS=Active
softlaunch

Bacterial Resistance to Antibiotics: From Molecules to Man

English

AN AUTHORITATIVE SURVEY OF CURRENT RESEARCH INTO CLINICALLY USEFUL CONVENTIONAL AND NONCONVENTIONAL ANTIBIOTIC THERAPEUTICS

Pharmaceutically-active antibiotics revolutionized the treatment of infectious diseases, leading to decreased mortality and increased life expectancy. However, recent years have seen an alarming rise in the number and frequency of antibiotic-resistant Superbugs. The Centers for Disease Control and Prevention (CDC) estimates that over two million antibiotic-resistant infections occur in the United States annually, resulting in approximately 23,000 deaths.

Despite the danger to public health, a minimal number of new antibiotic drugs are currently in development or in clinical trials by major pharmaceutical companies. To prevent reverting back to the pre-antibiotic erawhen diseases caused by parasites or infections were virtually untreatable and frequently resulted in deathnew and innovative approaches are needed to combat the increasing resistance of pathogenic bacteria to antibiotics.

Bacterial Resistance to Antibiotics From Molecules to Man examines the current state and future direction of research into developing clinically-useful next-generation novel antibiotics. An internationally-recognized team of experts cover topics including glycopeptide antibiotic resistance, anti-tuberculosis agents, anti-virulence therapies, tetracyclines, the molecular and structural determinants of resistance, and more.

  • Presents a multidisciplinary approach for the optimization of novel antibiotics for maximum potency, minimal toxicity, and appropriated degradability
  • Highlights critical aspects that may relieve the problematic medical situation of antibiotic resistance
  • Includes an overview of the genetic and molecular mechanisms of antibiotic resistance
  • Addresses contemporary issues of global public health and longevity
  • Includes full references, author remarks, and color illustrations, graphs, and charts

Bacterial Resistance to Antibiotics From Molecules to Man is a valuable source of up-to-date information for medical practitioners, researchers, academics, and professionals in public health, pharmaceuticals, microbiology, and related fields.

See more
Current price €47.49
Original price €49.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Boyan B. BonevB01=Nicholas M. BrownCategory1=Non-FictionCategory=PSAFCategory=PSGDCOP=United KingdomDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€20 to €50PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 567g
  • Dimensions: 165 x 239mm
  • Publication Date: 12 Apr 2019
  • Publisher: John Wiley and Sons Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9781119940777

About

BOYAN B. BONEV is Associate Professor in Biophysics and Structural Biology Faculty of Medicine & Health Sciences University of Nottingham UK. Dr. Bonev heads the Biomembrane NMR labs and is co-Director of the Dynamic Nuclear Magnetization Facility. NICHOLAS M. BROWN is clinical lead for medical microbiology at Addenbrooke's Hospital Cambridge. He is previous President and current Director of Public and Professional Engagement British Society for Antimicrobial Chemotherapy (BSAC).

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept